We are live on ! Find out more
SRDX

Surmodics
SRDX

Delisted

SRDX was delisted on the 18th of November, 2025.

Back to rankings

138 hedge funds and large institutions have $691M invested in Surmodics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more capital invested

Capital invested by funds: $532M → $691M (+$159M)

0.15% more ownership

Funds ownership: 89.39% → 89.55% (+0.15%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 50

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

1% less funds holding

Funds holding: 140 → 138 (-2)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2.13M

Holders
138
Holders Change
-2
Holders Change %
-1.43%
% of All Funds
2.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
49
Reduced
50
Closed
11
Calls
–
Puts
$2.13M
Net Calls
-$2.13M
Net Calls Change
-$1.76M

Top Buyers

Rank Fund Capital Flow
1
DGI
Disciplined Growth Investors
Minnesota
+$9.18M
2
BlackRock
BlackRock
New York
+$3.9M
3
SBH
Segall Bryant & Hamill
Illinois
+$3.25M
4
SCM
Soleus Capital Management
Connecticut
+$3.06M
5
RHJA
Rice Hall James & Associates
California
+$2.09M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$4.08M
2
Janus Henderson Group
Janus Henderson Group
-$3.48M
3
Deutsche Bank
Deutsche Bank
Germany
-$1.53M
4
Morgan Stanley
Morgan Stanley
New York
-$1.48M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$1.44M

SRDX Hedge Fund Activity: Q1 2021 in Review

138 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2021, worth a combined $691M — up 30% from $532M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SRDX and 10 opened new positions — a net loss of 1 holder — while 50 trimmed existing stakes and 49 added.

The largest buyer was Disciplined Growth Investors, adding an estimated $9.18M. The largest seller was Renaissance Technologies, cutting an estimated $4.08M.

  • 138 institutional investors held Surmodics (SRDX) as of Q1 2021, down from 140 in Q4 2020.
  • Funds reported $691M of Surmodics stock for Q1 2021, up 30% quarter-over-quarter.
  • 10 funds opened new Surmodics positions in Q1 2021 and 11 closed out, a net change of -1 holder.
  • The largest Surmodics buyer in Q1 2021 was Disciplined Growth Investors, an estimated $9.18M added.
  • The largest Surmodics seller in Q1 2021 was Renaissance Technologies, an estimated $4.08M sold.

Based on aggregated 13F filings for Q1 2021.